#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA856036	Functional	IC50 evaluated by measuring contraction and relaxation of guinea pig bladder strips with KCl and glibenclamide respectively	Cavia porcellus	77	ALA1129399	assay format	Scientific Literature
2.	ALA701213	Functional	Evaluated for K-ATP activity in terms of change in membrane potential through guinea pig bladder assay	Cavia porcellus	68	ALA1148324	cell membrane format	Scientific Literature
3.	ALA701216	Functional	Evaluated for K-ATP activity in terms of stable twitch response through field-stimulated landrace pig detrusor assay	Sus scrofa	36	ALA1148324	assay format	Scientific Literature
4.	ALA699663	Functional	Evaluated for K-ATP activity as in vitro bladder relaxation in spontaneous Landrace pig detrusor strips (SLPD)	Sus scrofa	6	ALA1148324	assay format	Scientific Literature
5.	ALA700931	Functional	In vitro ATP-sensitive potassium channel (KATP) activity in cells expressing human KATP channels Kir6.2 and sulfonylurea receptor 2B	Homo sapiens	1	ALA1148468	assay format	Scientific Literature
6.	ALA778525	Functional	In vivo concentration required for the reduction of mean arterial pressure in anesthetized obstructed male rat, administered intravenously at a dose of 50 nM/Kg	Rattus norvegicus	2	ALA1136389	organism-based format	Scientific Literature
7.	ALA776996	Functional	Compound was evaluated in vivo for the effective dose that cause a 20% drop in MAP normotensive rat after oral administration	Rattus norvegicus	4	ALA1132985	organism-based format	Scientific Literature
8.	ALA777591	Functional	Effective dose in vivo for reduction in MAP in normotensive rat model after oral administration	Rattus norvegicus	3	ALA1132984	organism-based format	Scientific Literature
9.	ALA783034	Functional	In vivo concentration required for the inhibition of unstable contraction in anesthetized obstructed male rat, administered intravenously at a dose of 30 nM/Kg	Rattus norvegicus	3	ALA1136389	organism-based format	Scientific Literature
10.	ALA785427	Functional	Compound was evaluated in vivo for the effective dose that cause a 50% reduction in frequency of spontaneous bladder contraction in the rat hypertrophied model after oral administration	Rattus norvegicus	8	ALA1132985	organism-based format	Scientific Literature
11.	ALA780594	Functional	Effective dose in vivo for reduction in the frequency of spontaneous bladder contractions in the rat oral administration	Rattus norvegicus	3	ALA1132984	organism-based format	Scientific Literature
12.	ALA779563	Functional	In vitro inhibitory concentration that relaxed KCL induced contraction in rat detrusor strip by 50%	Rattus norvegicus	77	ALA1132985	organism-based format	Scientific Literature
13.	ALA779564	Functional	In vitro inhibitory concentration that relaxes KCL induced contraction in rat detrusor strips by 50%	Rattus norvegicus	76	ALA1132984	organism-based format	Scientific Literature
14.	ALA849847	Functional	Selectivity ratio for the reduction of mean arterial pressure to that of unstable concentration in anesthetized obstructed male rat		3	ALA1136389	tissue-based format	Scientific Literature
15.	ALA846990	Functional	Selectivity expressed as the ratio of pEC50 (SLPD) and pEC50 (FSLPD)		6	ALA1148324	assay format	Scientific Literature
16.	ALA848710	Functional	Selectivity ratio of MAP ED20/bladder ED50		3	ALA1132984	assay format	Scientific Literature
17.	ALA848711	Functional	Selectivity ratio of MAP ED20/bladder ED50		4	ALA1132985	assay format	Scientific Literature
18.	ALA762565	Functional	In vitro functional potassium channel opening activity in tissue strips from Landrace pig bladders(LPD)	Sus scrofa	1	ALA1148468	assay format	Scientific Literature
19.	ALA767695	Functional	In vivo inhibion of pyruvate dehydrogenase kinase, increased oxidation of lactate	Homo sapiens	8	ALA1132309	organism-based format	Scientific Literature
20.	ALA767697	Binding	In vitro inhibitory activity against Pyruvate dehydrogenase kinase by primary enzymatic assay	Sus scrofa	18	ALA1132309	protein format	Scientific Literature